Abattis, GD Pharma sign distribution deal for S. Korea - Stockpools

Stockpools on your Phone

Follow Stockpools

Abattis, GD Pharma sign distribution deal for S. Korea

2017-10-03

VANCOUVER, British Columbia, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has reached a definitive agreement with Global Damon Pharma (“GD Pharma”) of South Korea, to distribute and sell Abattis’ product lines exclusively in South Korea. The agreement allows GD Pharma to begin sales of Abattis products in South Korea effective immediately.


Click here to read the original article.